MENVEO

Land: Indonesien

Sprache: Indonesisch

Quelle: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Wirkstoff:

MENINGOCOCCAL POLYSACCHARIDE GROUP A CONJUGATED TO CRM197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP C CONJUGATED TO CRM197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP W CONJUGATED TO CRM 197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP Y CONJUGATED TO CR

Verfügbar ab:

SMITHKLINE BEECHAM PHARMACEUTICALS - Indonesia

INN (Internationale Bezeichnung):

MENINGOCOCCAL POLYSACCHARIDE GROUP A CONJUGATED TO CRM197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP C CONJUGATED TO CRM197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP W CONJUGATED TO CRM 197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP Y CONJUGATED TO CR

Dosierung:

10 µG MENA OLIGOSACCHARIDE 16.7-33.3 µG CRM197 MCG /5 µG MENC OLIGOSACCHARIDE 7.1-12.5 µG CRM197 MCG

Darreichungsform:

SERBUK INJEKSI

Einheiten im Paket:

DUS, 1 DOSIS @ (1 VIAL SERBUK INJEKSI + 1 VIAL LARUTAN INJEKSI @ ...

Hergestellt von:

GLAXOSMITHKLINE VACCINES S.R.L - Italy

Berechtigungsdatum:

2021-05-24